Viatris (VTRS) Other Operating Expenses (2019 - 2026)
Viatris (VTRS) posted Other Operating Expenses of -$73.2 million for Q2 2026, down 36.82% on a QoQ basis from -$53.5 million in Q1 2026, and down 253.78% year-over-year from $47.6 million in Q2 2025.
Analysis
Viatris (VTRS) Other Operating Expenses (2019 - 2026) Analysis & Trends
Viatris has reported Other Operating Expenses for 8 years, with the latest figure at -$73.2 million in Q2 2026.
- On a quarterly basis, Other Operating Expenses fell 253.78% year-over-year to -$73.2 million in Q2 2026; TTM through Jun 2026 was -$179.3 million, a 715.0% decrease from a year earlier, with the FY2025 full-year figure at $68.5 million, up 119.52% from the prior year.
- Other Operating Expenses was -$73.2 million for Q2 2026 at Viatris, down from -$53.5 million in the prior quarter.
- The five-year high for Other Operating Expenses was $73.5 million in Q1 2025, with the low at -$148.1 million in Q4 2023.
- Average Other Operating Expenses over 5 years is -$29.2 million, with a median of -$8.5 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses soared 569.23% in 2023, then plunged 12700.0% in 2024.
- Over 5 years, Other Operating Expenses stood at $8.8 million in 2022, then plunged by 1782.95% to -$148.1 million in 2023, then grew by 24.65% to -$111.6 million in 2024, then soared by 102.78% to $3.1 million in 2025, then tumbled by 2461.29% to -$73.2 million in 2026.
- The last three Other Operating Expenses figures came in at -$73.2 million (Q2 2026), -$53.5 million (Q1 2026), and $3.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -73.20 Mn |
| Mar 31, 2026 | -53.50 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | -55.70 Mn |
| Jun 30, 2025 | 47.60 Mn |
| Mar 31, 2025 | 73.50 Mn |
| Dec 31, 2024 | -111.60 Mn |
| Sep 30, 2024 | -31.50 Mn |
| Jun 30, 2024 | -131.00 Mn |
| Mar 31, 2024 | -76.80 Mn |
| Dec 31, 2023 | -148.10 Mn |
| Sep 30, 2023 | 26.10 Mn |
| Jun 30, 2023 | 11.00 Mn |
| Mar 31, 2023 | -600,000.00 |
| Dec 31, 2022 | 8.80 Mn |
| Sep 30, 2022 | 3.90 Mn |
| Jun 30, 2022 | -10.90 Mn |
| Mar 31, 2022 | -6.20 Mn |
| Dec 31, 2021 | -273.90 Mn |
| Sep 30, 2021 | -9.40 Mn |